ALK and anaplastic large cell lymphoma: BIA-ALCL was first described in 1997 [93] but it was recognized in 2016 by the World Health Organization (WHO) as a unique T-cell ALK-negative ALCL, with similar morphologic and immunophenotypic characteristics to systemic and cutaneous ALK-negative BIA-ALCL [94].